These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17444846)

  • 1. TNF-alpha as therapeutic target in NASH: tried, but not yet proven.
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2007 May; 22(5):613-4. PubMed ID: 17444846
    [No Abstract]   [Full Text] [Related]  

  • 2. Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis.
    Satapathy SK; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2007 May; 22(5):634-8. PubMed ID: 17444848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
    Satapathy SK; Garg S; Chauhan R; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
    Am J Gastroenterol; 2004 Oct; 99(10):1946-52. PubMed ID: 15447754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone trial for NASH: results show promise.
    Lang L
    Gastroenterology; 2007 Mar; 132(3):836-8. PubMed ID: 17383411
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 6. Adipokines and liver fibrosis.
    Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
    Eur Rev Med Pharmacol Sci; 2005; 9(5):279-84. PubMed ID: 16231590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiopathogenesis of liver cirrhosis].
    Cerlek S
    Wien Z Inn Med; 1967; 48(5):196-203. PubMed ID: 5620280
    [No Abstract]   [Full Text] [Related]  

  • 9. Betaine: an old therapy for a new scourge.
    Neuschwander-Tetri BA
    Am J Gastroenterol; 2001 Sep; 96(9):2534-6. PubMed ID: 11569673
    [No Abstract]   [Full Text] [Related]  

  • 10. The mechanism behind the novel fibrosis recently described in NASH in HEPATOLOGY 2011 and elsewhere.
    Hemsworth-Peterson TC
    Hepatology; 2012 Oct; 56(4):1585. PubMed ID: 22505349
    [No Abstract]   [Full Text] [Related]  

  • 11. Pentoxifylline in the management of metabolic syndrome and chronic hepatitis C.
    Metwally AH
    Med Hypotheses; 2014 Dec; 83(6):832-4. PubMed ID: 25468788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous liver biopsy in diabetics--experiences between 1968 and 1971].
    Schmidt R; Tennstedt A
    Z Arztl Fortbild (Jena); 1974 Mar; 68(6):298-302. PubMed ID: 4418773
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis.
    Aithal GP; Thomas JA; Kaye PV; Lawson A; Ryder SD; Spendlove I; Austin AS; Freeman JG; Morgan L; Webber J
    Gastroenterology; 2008 Oct; 135(4):1176-84. PubMed ID: 18718471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid progression of NASH in childhood.
    Kohli R; Boyd T; Lake K; Dietrich K; Nicholas L; Balistreri WF; Ebach D; Shashidhar H; Xanthakos SA
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):453-6. PubMed ID: 20179647
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
    Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
    Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
    Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
    J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is pentoxifylline the answer for alcoholic hepatitis?
    Sapra B; Chawla Y
    Trop Gastroenterol; 2002; 23(1):1-2. PubMed ID: 12170912
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of the new plant hepatoprotector--Ropren in patients with non-alcoholic steatohepatitis].
    Golovanova EV; Vinnitskaia EV; Shaposhnikova NA; Petrakov AV; Mel'kina ES
    Eksp Klin Gastroenterol; 2010; (7):97-102. PubMed ID: 21033090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seek and hide phosphatidylserine: a new approach to prevent hepatic ischemia/reperfusion injury.
    Albano E
    Gastroenterology; 2007 Aug; 133(2):713-6. PubMed ID: 17681189
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.
    Samuhasaneeto S; Thong-Ngam D; Kulaputana O; Patumraj S; Klaikeaw N
    J Med Assoc Thai; 2007 Apr; 90(4):788-97. PubMed ID: 17487136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.